These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 35150232)
1. An Analysis of the Sensitivity of the Activated Partial Thromboplastin Time (APTT) Assay, as Used in a Large Laboratory Network, to Coagulation Factor Deficiencies. Do L; Favaloro E; Pasalic L Am J Clin Pathol; 2022 Jul; 158(1):132-141. PubMed ID: 35150232 [TBL] [Abstract][Full Text] [Related]
2. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors. Favaloro EJ; Kershaw G; Mohammed S; Lippi G Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies. Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235 [TBL] [Abstract][Full Text] [Related]
4. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level. Baig MA; Swamy KB Indian J Pathol Microbiol; 2021; 64(1):123-127. PubMed ID: 33433421 [TBL] [Abstract][Full Text] [Related]
8. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats]. Deniz A; Mischke R; Nolte I Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777 [TBL] [Abstract][Full Text] [Related]
9. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time. Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757 [TBL] [Abstract][Full Text] [Related]
10. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Welsch DJ; Novotny WF; Wun TC Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A. Gu JM; Ramsey P; Evans V; Tang L; Apeler H; Leong L; Murphy JE; Laux V; Myles T Haemophilia; 2014 Jul; 20(4):593-600. PubMed ID: 24471985 [TBL] [Abstract][Full Text] [Related]
12. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. Burns ER; Goldberg SN; Wenz B Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955 [TBL] [Abstract][Full Text] [Related]
13. Activated partial thromboplastin time and minor coagulopathies. Hathaway WE; Assmus SL; Montgomery RR; Dubansky AS Am J Clin Pathol; 1979 Jan; 71(1):22-5. PubMed ID: 420168 [TBL] [Abstract][Full Text] [Related]
14. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Shima M; Matsumoto T; Fukuda K; Kubota Y; Tanaka I; Nishiya K; Giles AR; Yoshioka A Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076 [TBL] [Abstract][Full Text] [Related]
15. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions. Barna L; Triplett DA Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350 [TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of a new synthetic APTT reagent. Ts'ao C; Neofotistos D; Oropeza M; Rogan M; Santos M Clin Lab Haematol; 1998 Oct; 20(5):307-13. PubMed ID: 9807679 [TBL] [Abstract][Full Text] [Related]
17. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency. Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR Blood; 1984 May; 63(5):1004-14. PubMed ID: 6713090 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies. Turi DC; Peerschke EI Am J Clin Pathol; 1986 Jan; 85(1):43-9. PubMed ID: 3940420 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of APTT Mixing Test Results in Factor Ⅷ Inhibitor-Positive Hemophilia Patients]. Zhang LH; Xie ZQ; Zhuang H; Wang MH; Cao YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1791-1796. PubMed ID: 38071062 [TBL] [Abstract][Full Text] [Related]
20. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents. Ten Boekel E; Böck M; Vrielink GJ; Liem R; Hendriks H; de Kieviet W Thromb Res; 2007; 121(3):361-7. PubMed ID: 17568658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]